A carregar...

A Current Perspective on Daptomycin for the Clinical Microbiologist

SUMMARY: Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-positive bacteria that was first approved for clinical use in 2004 in the United States. Since this time, significant data have emerged regarding the use of daptomycin for the treatment of serious inf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Humphries, Romney M., Pollett, Simon, Sakoulas, George
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811228/
https://ncbi.nlm.nih.gov/pubmed/24092854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.00030-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!